Similar articles for PMID: 24868338

Year	Number of Results
2006	1
2007	1
2008	3
2009	3
2010	7
2011	13
2012	8
2013	11
2014	12
2015	11
2016	10
2017	11
2018	10
2019	8
2020	6
2021	2
2024	0

1

Efficacy and Safety of the Selective α1A-Adrenoceptor Blocker Silodosin for Severe Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Prospective, Single-Open-Label, Multicenter Study in Korea.

Moon KH, Song PH, Yang DY, Park NC, Kim SW, Lee SW, Kim SW, Moon du G, Park JK, Ahn TY, Park K. Moon KH, et al. Korean J Urol. 2014 May;55(5):335-40. doi: 10.4111/kju.2014.55.5.335. Epub 2014 May 12. Korean J Urol. 2014. PMID: 24868338 Free PMC article.

2

Silodosin, a new alpha1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men.

Kawabe K, Yoshida M, Homma Y; Silodosin Clinical Study Group. Kawabe K, et al. BJU Int. 2006 Nov;98(5):1019-24. doi: 10.1111/j.1464-410X.2006.06448.x. Epub 2006 Aug 31. BJU Int. 2006. PMID: 16945121 Clinical Trial.

3

[Investigation of adverse events and the continuance rate of silodosin in all patients who received silodosin for lower urinary tract symptoms suggestive of benign prostatic hyperplasia].

Furuya R, Masumori N, Furuya S, Ogura H, Mutoh M, Kobayashi K, Hisasue S, Tsukamoto T. Furuya R, et al. Nihon Hinyokika Gakkai Zasshi. 2010 Jan;101(1):13-7. doi: 10.5980/jpnjurol.101.13. Nihon Hinyokika Gakkai Zasshi. 2010. PMID: 20158073 Japanese.

4

Individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH): subgroup analyses of efficacy and safety data.

Novara G, Chapple CR, Montorsi F. Novara G, et al. BJU Int. 2015 May;115(5):802-14. doi: 10.1111/bju.12906. BJU Int. 2015. PMID: 25130493

5

[Optimum initial dose of silodosin for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia].

Wada N, Numata A, Yamaguchi S, Osanai H, Mori T, Hou K, Fujisawa M, Kaneko S, Kakizaki H. Wada N, et al. Hinyokika Kiyo. 2011 Jun;57(6):297-302. Hinyokika Kiyo. 2011. PMID: 21795831 Free article. Japanese.

6

Comparison of Silodosin Monotherapy vs Silodosin With Tadalafil Add-on Therapy in Patients With Benign Prostatic Hyperplasia.

Yoshida T, Kinoshita H, Shimada S, Taguchi M, Matsuda T. Yoshida T, et al. Urology. 2017 Aug;106:153-159. doi: 10.1016/j.urology.2017.04.012. Epub 2017 Apr 18. Urology. 2017. PMID: 28431996

7

[Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe].

Chapple ChR, Montorsi F, Tammela TL, Wirth M, Koldewijn E, Fernandez Fernandez E. Chapple ChR, et al. Urologiia. 2012 Sep-Oct;(5):38-42, 44-5. Urologiia. 2012. PMID: 23342615 Clinical Trial. Russian.

8

A meta-analysis of efficacy and safety of the new α1A-adrenoceptor-selective antagonist silodosin for treating lower urinary tract symptoms associated with BPH.

Wu YJ, Dong Q, Liu LR, Wei Q. Wu YJ, et al. Prostate Cancer Prostatic Dis. 2013 Mar;16(1):79-84. doi: 10.1038/pcan.2012.36. Epub 2012 Sep 18. Prostate Cancer Prostatic Dis. 2013. PMID: 22986578

9

Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe.

Chapple CR, Montorsi F, Tammela TL, Wirth M, Koldewijn E, Fernández Fernández E; European Silodosin Study Group. Chapple CR, et al. Eur Urol. 2011 Mar;59(3):342-52. doi: 10.1016/j.eururo.2010.10.046. Epub 2010 Nov 10. Eur Urol. 2011. PMID: 21109344 Clinical Trial.

10

Safety and efficacy of tamsulosin, alfuzosin or silodosin as monotherapy for LUTS in BPH - a double-blind randomized trial.

Manohar CMS, Nagabhushana M, Karthikeyan VS, Sanjay RP, Kamath AJ, Keshavamurthy R. Manohar CMS, et al. Cent European J Urol. 2017 Jun 30;70(2):148-153. doi: 10.5173/ceju.2017.924. Epub 2017 Jun 7. Cent European J Urol. 2017. PMID: 28721281 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

97 results

Results by year